Диссертация (1154915), страница 18
Текст из файла (страница 18)
2146–2152.52.Cook, S. High heart rate: a cardiovascular risk factor? /Cook S., Togni M.,Schaub M.C., Wenaweser P., Hess O.M.// Eur Heart J. – 2006. - №27. - Р. 2387–2393.53.Custodis, F. Vascular pathophysiology in response to increased heart rate./111Custodis F., Shirmer S.H., Baumhakel M. et al.// JACC. – 2010. - №56. - Р. 1973–1983.54.De Vos C.B. Atrial tissue Doppler imaging for prediction of new-onset atrialfibrillation.
/De Vos C.B., Weijs B., Crijns H.J. et al. //Heart. – 2009. - №95. – Р.835-840.55.Deepak K.G. Left atrial structure and function in atrial fibrillation:ENGAGE AF-TIMI 48. /Deepak K.G., Amil M.S., Giugliano P.R. et al.//EurHeartJ. – 2014. - №35. – Р. 1457–1465.56.Ding F.H., Impact of heart rate on central hemodynamics and stroke: ameta-analysis of β-blocker trials./ Ding F.H., Li Y., Li L.H., Wang J.G.//Am JHypertens. – 2013. - №26(1).
– Р. 118-125.57.Dittrich H.C. Left atrial diameter in nonvalvular atrial fibrillation enechocardiographic study. Stroke prevention in atrial fibrillation investigations./Dittrich H.C., Pearce L.A., Asinger R.W. et al. //Am Heart J. – 1999. - №137. – Р.494-499.58.Dorian P.
The impairment of health-related quality of life in patients withintermittent atrial fibrillation: implications for the assessment of investigationaltherapy./ Dorian P., Jung W., Newman D. et al.// JACC. – 2000. - №36. – Р. 1303—1309.59.Emara M.K. Transient atrial fibrillation in hypertensive patients withthiazide induced hypokalaemia. / Emara M.K., Saadet A.M. //Postgrad Med J. –1986. - №62. – Р.
1125-1127.60.Eshoo S. Strain rate evaluation of phasic atrial function in hypertension./Eshoo S., Boyd A.C., Ross D.L. et al. //Heart. – 2009. - №95. – Р. 1184-1191.61.Facila L. Twenty-four-hour ambulatory heart rate and organ damage inprimary hypertension. /Facila L., Pallares V., Peset A., Perez M., Gil V., MontagudV.
et al.// Blood Press. – 2010. - №19. - Р. 104–109.62.Farinaro E. Heart rate as a risk factor in hypertensive individuals: the ItalianTensioPulse Study. / Farinaro E., Stranges S., Guglielmucci G., Iermano P.,Celentano E. et al. // Nutr Metab Cardiovasc Dis. – 1999. - №9. Р. 196 –202.11263.Fogari R. Losartan and prevention of atrial fibrillation recurrence inhypertensive patients. / Fogari R., Mugellini A., Destro M. et al.
//J CardiovascPharmacol. – 2006. - №47(1). – Р. 46-50.64.Fornengo C. Prediction of atrial fibrillation recurrence after cardioversion inpatients with left-atrial dilation. /Fornengo C., Antolini M., Frea S. et al. //EurHeart J Cardiovasc Imaging. – 2015. - №16. – Р. 335-341.65.Fox K. The Heart Rate Working Group. Resting heart rate in cardiovasculardisease. / Fox K., Borer J.S., Camm J., Danchin N., Ferrari R. et al.
//JACC. –2007. - №50. - Р. 823–830.66.Furberg C.D. Prevalence of atrial fibrillation in elderly subjects (theCardiovascular Health Study). /Furberg C.D., Psaty B.M., Manolio T.A., GardinJ.M., Smith V.E., Rautaharju P.M.// Am J Cardiol. – 1994. - №74. – Р. 236–241.67.Garsia-Acuna J.M. Permanent atrial fibrillation in heart disease in Spain.The CARDIOTENS study 1999. /Garsia-Acuna J.M., Gonsalez-Juanatey J.R.,Ezquerra A.
et al. //Rev Esp Cardiol. – 2002. - № 55(9). – Р. 943-95268.Giannattasio C. Effects of Heart Rate Changes on Arterial Distensibility inHumans. /Giannattasio C., Vincenti A., Failla M. et al. // J Hypertens. – 2003. №42. - Р. 253–256.69.Gillman M.W. Influence of heart rate on mortality among persons withhypertension: the Framingham Study. /Gillman M.W., Kannel W.B., Belanger A.,D’Agostino R.B.// Am Heart J.
– 1993. – №125. – Р. 1148 –1154.70.Gottdiener J.S. Clinical trials of single-drug therapy for the cardiac effects ofhypertension. Am J Hypertens. - 1999. - №12. – Р.12–18.71.Govindan M. Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrialfibrillation recurrence. /Govindan M., Borgulya G., Kiotsekoglou A. et al.//Europace. – 2012.
- №14. – Р. 1302–1310.72.Grönefeld G.C. Quality of life in atrial fibrillation: an increasingly importantissue. /Grönefeld G.C., Hohnloser S.H.// Eur Heart J. – 2003. - №5 (Suppl H). – Р.25-33.11373.Grundvold I. Low heart rates predict incident atrial fibrillation in healthymiddle-aged men. /Grundvold I., Skretteberg P.T., Liestøl K. at al. //Circ ArrhythmElectrophysiol. – 2013. - № 6(4). – Р. 726-731.74.Gupta S. Left atrial structure andfunction and clinical outcomes in thegeneral population.
/Gupta S., Matulevicius S.A., Ayers C.R., et al. //Eur Heart J. 2013. - №34. – Р. 278–85.75.Ha J.W. Therapeutic Strategies for Diastolic Dysfunction: A ClinicalPerspective. /Ha J.W., Oh J.K.// J Cardiovasc Ultrasound. – 2009. - № 17(3). – Р.86–95.76.Hayes C. Control of hypertension improves the outcome of therapies forparoxysmal and persistent atrial fibrillation. J of Atrial Fib. – 2014. - №7 (2).
– Р.55-58.77.Heckbert S.R. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population./ Heckbert S.R., Wiggins K.L., Glazer N.L. et al.//Am J Hypertens. – 2009. -№22. – Р. 538-544.78.HohnloserS.H.Rhythmorratecontrolinatrialfibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial./Hohnloser S.H., Kuck K.H., Lilienthal J. //Lancet. – 2000.
- №356. – Р. 1789—1794.79.Hoit B.D. Left atrial size and function. Role in prognosis. JACC – 2014. -№63 (6). – Р. 493-505.80.Horio T. Chronic kidney disease as an independent risk factor for new-onsetatrial fibrillation in hypertensive patients. /Horio T., Iwashima Y., Kamide K. etal.// J Hypertens. - 2010. - №28. – Р. 1738–1744.81.Hsiao S.H. and Chiou K.R. Left atrial expansion index predicts all-causemortality and heart failure admissions in dyspnoea. Eur J of Heart Failure.
2013; 1:1245–1252.82.Hsiao S.H. Left atrial expansion index predicts atrial fibrillation in dyspnea./Hsiao S.H., Chiou KR.// Circulation. – 2013. - №77(11). – Р. 2712-2721.11483.http://history.amedd.army.mil/biographies.html84.Ichihara A. Long-term effects of intensive blood pressure lowering onarterial wall stiffness in hypertensive patients. /Ichihara A., Hayashi M., Koura Y.et al.// Am J Hypertens. – 2003. - № 16(11). – Р. 959-965.85.Iguchi Y. Relation of atrial fibrillation to glomerular filtration rate. / IguchiY., Kimura K., Kobayashi K., Aoki J., Terasawa Y., Sakai K.
et al. //Am J Cardiol.- 2008. - №102. – Р. 1056–1059.86.IlicetoS.Leftventriculardysfunction:whichroleforcalciumantagonists? Eur Heart J. 1997;18: 87–91.87.Inoue T. Higher heart rate predicts the risk of developing hypertension in anormotensive screened cohort./ Inoue T., Iseki K., Iseki C. et al. //Circulation. 2007. - №71. Р. 1755–1760.88.Inoue T. Heart rate as a risk factor for developing chronic kidney disease:longitudinal analysis of a screened cohort. /Inoue T., Iseki K., Iseki Cet al.
//ClinExp Nephrol. – 2009. - №13. – Р. 487– 493.89.Julius S., Palatini P., Kjeldsen S. et al. Tachycardia predicts cardiovascularevents in the VALUE trial. American Society of Hypertension 2010, ScientificMeeting; May 1–4, 2010; New York, NY. Abstract LB-OR-01.90.Jurkevicius R. Effects of beta blockers on left ventricular diastolic function:the importance of optimal heart rate reduction.
/Jurkevicius R., SakalyteG., Kavoliŭniene A. //Acta Cardiol. – 2007. - №62(3). – Р. 269-274.91.Kaji Y. Augmentation index is associated with B-type natriuretic peptide inpatients with paroxysmal atrial fibrillation. /Kaji Y., Miyoshi T., Doi M. et al.//Hypertension Research. – 2009. - №32. – Р.
611–616.92.Kampus P. Differential effects of nebivolol and metoprolol on central aorticpressure and left ventricular wall thickness. /Kampus P., Serg M., Kals J., ZaguraM. et al.// J Hypertens. – 2011. - №57(6). – Р. 1122-1128.93.Kidher E.
High aortic pulse wave velocity is associated with poor quality oflife in surgical aortic valve stenosis patients./Kidher E., Harling L.,Nihoyannopoulos P. et al. //Interactive CardioVascular and Thoracic Surgery. –1152014. Р. 1–9.94.King D.E. Long-term prognostic value of resting heart rate in subjects withprehypertension. /King D.E., Everett C.J., Mainous A.G., Liszka H.A.// Am JHypertens.
– 2006. - №19. – Р. 796–800.95.Klocek M. Quality of life in patients with essential arterial hypertension.Part I: The effect o socio-demographic factors. /Klocek M., Kawecka-Jaszcz K.//Przegl Lek. – 2003. - №60(2). – Р. 92-100.96.Kolloch R. Impact of resting heart rate on outcomes in hypertensive patientswith coronary artery disease: findings from the INternational VErapamilSR/trandolapril STudy (INVEST). / Kolloch R., Legler U.F., Champion A. et al.//Eur Heart J. – 2008.
- № 29. - Р. 1327–1334.97.Kühlkamp V. Use of metoprolol CR/XL to maintain sinus rhythm afterconversion from persistent atrial fibrillation: a randomized double blind placebocontrolled study. /Kühlkamp V., Schirdewan A., Stangl K. et al. //J Am CollCardiol. – 2000. - №36. – Р. 139–146.98.Kurt M. Left atrial function in diastolic heart failure. /Kurt M., Wang J.,Torre-Amione G., Nagueh S.F. // Circ Cardiovasc Imaging. – 2009. - №2(1). – Р.10-15.99.Lang R.M., Badano L.P., Mor-Avi V., Afilano J et al.
Recommendations forcardiac chamber quantification by echocardiography in adults: an update from theAmerican Society of Echocardiography and the European Assosiation ofCardiovascular Imaging. Eur Heart J Cardiovascular Imaging. 2015; 16: 233-271.100. Lantelme P., Laurent S., Besnard C. et al. Artelial stiffness is accotiated withleft atrial sixe in hypertensive patients. Arch of Cardiovascular Diseases. 2008;101: 35-40101. Lantelme P. Heart rate: an important confounder of pulse wave velocityassessment. /Lantelme P., Mestre C., Lievre M., Gressard A., Milon H.//JHypertens.
- 2002. - №39. – Р. 1083-1087.102. Larstorp A.K. Association of Pulse Pressure With New-Onset AtrialFibrillation in Patients With Hypertension and Left Ventricular Hypertrophy The116Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study. /Larstorp A.K.,Ariansen I., Gjesdal K., Michael H., Olsen M.H. et al. // JHypertens. – 2012. - №60. – Р. 347-353.103. Lau D.H., Middeldorp M.E., Brooks A.G. et al. Aortic Stiffness in LoneAtrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence. 2013; 8(10):e76776.104. Laurent S., Cockcroft J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
